suma/消炎（药

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention concerns a new cosmetic preparation containing peptide derivatives derived from .alpha.-MSH (melanocyte stimulating hormone) and other active ingredients. 2. The Prior Art .alpha.-MSH has already been investigated by a number of

The present invention relates to the novel addition compound between econazole and acexamic acid, having formula (I) ##STR1## The present invention relates also to processes for preparing compound (I) as well as pharmaceutical compositions containing compound (I) as the active principle,

This is a 371 of PCT/EP96/01936 filed May 9, 1996. SUBJECT OF THE INVENTION The invention relates to the subjects that are characterized in the claims, i.e., the use of nonsteroidal anti-inflammatory agents to improve the physiological compatibility of particulate pharmaceutical agent

The present invention is directed to novel 6-1H-imidazo-2-aryl and 2-heteroaryl quinazoline and quinolines, to a process for their preparation, to their pharmaceutical compositions and to the use of such compounds and their pharmaceutical compositions for the treatment of pain and inflammatory

The present invention is directed to novel 6-1H-imidazo-2-aryl and 2-heteroaryl quinazoline and quinolines, to a process for their preparation, to their pharmaceutical compositions and to the use of such compounds and their pharmaceutical compositions for the treatment of pain and inflammatory

BACKGROUND OF THE INVENTION 2,3,4,5-Tetrahydro-1-benzazepine-2,5-dione-4-carboxylic acids and their alkyl esters have been described by Geissman et al in J. Org. Chem. 24, 41 (1959) as alkaloid-intermediates, and their "rearrangement in aqueous acid and base to 2,4-dihydroxy-quinoline-3-acetic acid"

BACKGROUND The present invention relates to anti-inflammatory compositions and, more particularly, to topical anti-inflammatory compositions. The compositions of the present invention have particular use as cosmetic and/or dermopharmaceutical compositions. Human skin is subjected to numerous

FIELD OF THE INVENTION Disclosed herein is a method for in vitro screening of nonsteroidal anti-inflammatory agents by aggregometry of dissociated sponge cells. BACKGROUND OF THE INVENTION Inflammation has several characteristic processes including permeability changes in the microvasculature,

BACKGROUND OF THE INVENTION This invention relates to topically-active anti-inflammatory 3-chloro-5,6-diaryl-1,2,4-triazines, to a method of treating inflammation, and to a composition suitable for treating inflammation. Inflammation is an essentially protective and normal response to injury,

BACKGROUND OF THE INVENTION This invention relates to imidazole derivatives, pharmaceutical compositions containing them and methods of using them to treat inflammation in mammals. More particularly, this invention relates to antiinflammatory 4,5-diaryl-b 2-haloimidazoles. A few such compounds are

TECHNICAL FIELD The present invention relates to a nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic that is excellent in percutaneous absorption and stability. BACKGROUND ART Nonsteroidal anti-inflammatory analgesics do not show severe

FIELD OF THE INVENTION The present invention relates to an antiinflammatory gel preparation which can contain diclofenac or a salt thereof a high concentration and which exhibits superior stability and excellent percutaneous absorptivity. DESCRIPTION OF THE BACKGROUND ART Diclofenac or its salts

BACKGROUND OF THE INVENTION The present invention is novel compounds which are 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and methods of use therefor. The invention compounds are now found to have

The present invention provides 1-methyl-4-piperidinol esters of the formula: ##STR2## in which R is selected from the group consisting of 7-chloro-4-quinolyl, 7-trifluoromethyl-4-quinolyl and 8-trifluoromethyl-4-quinolyl. The present invention also provides acid addition salts of the compounds of

FIELD The present invention relates to a depot for drug delivery. In particular the present invention relates to a depot suitable for sustained-release drug delivery. Further the present invention relates to use of a depot in the preparation of a parenteral sustained-release medicament. In